{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KXj0PYLDA","lastupdate":"2023-03-20T00:00:00.000Z","update_date":"2023-03-20T00:00:00.000Z","lastModified":"Dec 22, 2024","active":1,"confidence_score":100,"confidence_score_reason":"video or image, markets","urlname":"panacea-ml","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$SQLubmi6UarQh2L1UldHkmht32oNI2tdI4hMHGtndORZNhVWBasrUY.png","name":"Panacea-ml","oneliner":"Explainable-AI Platform to Streamline Clinical Trial Design","registrar":"516664000","website":"https://www.panacea-ml.com/","careerspage":"","founded_month":8,"founded_year":2022,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/93346721","instagram":""},"social":["https://app.dealroom.co/companies/panacea_ml/","https://www.linkedin.com/company/93346721","https://www.crunchbase.com/organization/panacea-ml","https://www.f6s.com/panacea-ml","https://app.vestbee.com/s/panaceaml/ae27d2076b9a4eb99e952fd2b51e901e"],"flattenedsociallinks":"https://app.dealroom.co/companies/panacea_ml/|https://www.linkedin.com/company/93346721|https://www.crunchbase.com/organization/panacea-ml|https://www.f6s.com/panacea-ml|https://app.vestbee.com/s/panaceaml/ae27d2076b9a4eb99e952fd2b51e901e","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"1-10","employees_exact":4,"patent":0,"raised":0,"stage":"Pre-Seed","public_stage":"Pre-Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Pancea","Panacea ML","Panacea"],"about":"Spun out of Ben Gurion University, Panacea-ml is disrupting clinical development with its “Explainable AI” platform. \n\nWe tackle the main causes of trial failures: patient population heterogeneity, poor trial design, and the limits of biostatistics. Together these problems are responsible for more than 85% of trial failures not related to drugs' mechanism of action, resulting in $70 billion annual waste and declining pharma R&D ROI. \n\nPanacea-ml's solution enables faster market access for new therapies with actionable predictive insights empowering clinical development and data science teams to de-risk, accelerate, and optimize trial designs. Our cutting-edge SaaS platform driven by our proprietary explainable AI is designed to redefine clinical development as our technology uncovers causal relationships between clinical markers, disease progression, and drug responses.\n\nUnlike traditional AI black-box models, Panacea-ml leverages causal discovery theory with its proprietary graphical models to not only predict clinical trials outcomes by to provide transparent, clinically-relevant insights into the ‘why’ behind the outcomes. This unique approach enhances predictive accuracy and enables actionable insights, improving trial success rates and R&D teams’ productivity.\n\nWe validated our explainable-AI across 8 trials in areas like Diabetes, ALS, rare diseases, and oncology, where we enabled a 30% reduction in participants without compromising statistical power and a 60% increase in patient retention. Our platform also rescued a development program in diabetes after a failed Phase 3 trial.\n\nWe target the $6B Data Analytics and Design segment of the $50B clinical trial market, focusing on high-failure areas like neurology and immuno-metabolic diseases.\n\nPanacea-ml aims to improve patients’ clinical outcomes, enhance their quality of life and accelerate access to life-treating therapies by redefining clinical development and empower pharma with advanced AI-analytic tools.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"fbe62f4c-b7f3-441e-ae1a-2ced54494819","city":"Ra'anana","type":null,"address":"Zarhin St 13, Ra'anana, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"9ZyitB8cIogTUAyLF60Fqq8dnnk9IrkfDL2e9WewkzmlAEjhfmJi6y","date":"Jul 10, 2024","link":"https://www.einpresswire.com/article/726692445/pharmstars-announces-the-first-startup-from-israel-to-graduate-from-its-accelerator-program-panacea-ml","source":"www.einpresswire.com","visible":1,"analysis":{"tags":"Graduation, Accelerator Program","company":"Panacea-ml","layoffs":"N/A","summary":"Panacea-ml, an Israeli startup, has graduated from PharmStars, a pharma-focused accelerator for digital health startups. The company, which focuses on revolutionizing clinical trial design and clinical development decision-making with cutting-edge explainable AI, was part of the Spring 2024 cohort focused on Digital Innovations in Oncology. The graduation marks the successful completion of PharmStars 10-week educational and mentoring program, PharmaU. The program prepares startups to effectively engage with pharma companies as clients and partners.","partners":["PharmStars"],"customers":"N/A","investors":"N/A","confidence":9,"key_topics":["PharmStars Accelerator","Digital Health Startup","Clinical Trial Design","AI Technology","Pharma Partnerships"],"date_of_event":"July 11, 2024","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Partners"],"acquisition_amount":"N/A","structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zFQYJgYjLfuEE33Yui11NUbmZQXWjUWUTOoci26cp6hxtRpqQqV0Ef","news_summary":"PharmStars Announces the First Startup from Israel  to Graduate from its Accelerator Program: Panacea-ml","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"cJ3WIW8KWjfeed80G9jw61xQkEKFHONrenYeEQ1xmBuKXLNjEyvr2y","date":"Jul 2, 2024","link":"https://www.einpresswire.com/article/723483711/pharmstars-announces-spring-2024-graduates-10-digital-health-startups-complete-pharmstars-pharma-focused-accelerator","source":"www.einpresswire.com","visible":1,"analysis":{"tags":"Digital Health, Startups, Accelerator Program","company":"PharmStars","layoffs":"Not mentioned","summary":"PharmStars, a pharma-focused accelerator for digital health startups, has announced the graduation of 10 startups from its Spring 2024 program. The program, which focused on Digital Innovations in Oncology, included a 10-week educational and mentoring program called PharmaU. The graduating startups, which were selected from applicants from 16 countries, each offer a unique digital health solution related to digital innovations in oncology. The startups presented their solutions to PharmStars’ pharma members at a Showcase Event in Boston, and participated in one-on-one meetings with them.","partners":"Graduating startups","customers":"Pharma members","investors":"Not mentioned","confidence":9,"key_topics":"Digital Innovations, Oncology, PharmaU Program, Startup Graduation, Showcase Event","date_of_event":"July 2, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Customers, Partners, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Partners, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yBq8b9CVlydOMsFbFun0Wwo3MV7jqcAwk99XvNzgBkZkNtmdcnc0Qi","news_summary":"PharmStars Announces Spring 2024 Graduates: 10 Digital Health Startups Complete PharmStars’ Pharma-focused Accelerator ","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"NO6K2UrnHSyMOCRdi12ETsXLJLSOiW1RqKNtdcpNG776KCnHM4GPvt","date":"May 27, 2024","link":"https://www.mako.co.il/nexter-news/Article-e7a060e3029bf81026.htm","source":"www.mako.co.il","visible":1,"analysis":{"tags":"Investment, Partnership, Expansion","company":"Predicta Med","layoffs":"Not mentioned","summary":"Predicta Med, an Israeli startup, is developing an AI-based platform for early detection and treatment of autoimmune diseases. The company was founded in 2020 and has since partnered with institutions such as Maccabi Health Services Research Institute and US hospitals including Cedars Sinai, Mayo Clinic, and Stanford. Predicta Med has raised over $4.5 million in its previous funding round and is currently closing a Seed round with strategic investors including Cedars Sinai, Mayo Clinic, leading funds in the field, and grants from Google and the Israel Innovation Authority.","partners":["Maccabi Health Services Research Institute","Cedars Sinai","Mayo Clinic","Stanford"],"customers":"Not mentioned","investors":["Arieli Capital","Shaare Zedek Medical Center","Cedars Sinai","Mayo Clinic","Google","Israel Innovation Authority"],"confidence":9,"key_topics":["Artificial Intelligence","Healthcare","Autoimmune Diseases","Investment","Partnership"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Over $4.5 million","structured_issues":["Investment","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"lWJWakbH2sleCwqUot7lSKyTZRFrDMhTQ5sNrjEkc2KdivWdGuV9N5","news_summary":"The program that will help startups in the medical field to save lives","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1FJgMeGV7GN1yYACJGI2Mw9j31zczk1Bk2J3awinMcPbGWVv1J6fPy","date":"Apr 30, 2024","link":"https://www.calcalistech.com/ctechnews/article/h1wa7gab0","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Innovation, Investment, Startups","company":"Arieli Capital, Shaare Zedek Medical Center","layoffs":"N/A","summary":"Shaare Zedek Medical Center and investment firm Arieli Capital have launched the first cohort of their innovation hub, SHAAR. The hub, located within Shaare Zedek Medical Center, provides startups with immediate proximity to physicians, data, and medical departments. Ten startups in the Seed to A stages were selected for the first cohort, which concluded last week. The program included 440 business meetings and collaboration opportunities for clinical trials partnerships and funding opportunities. The selected companies tackled various medical concerns, such as lung cancer, brain stents, and post-surgical infections.","partners":"Shaare Zedek Medical Center","customers":"N/A","investors":"Arieli Capital","confidence":9,"key_topics":"Innovation Hub, Biomed Companies, Clinical Trials, Medical Advancements","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"$25 million","structured_issues":"Investment, Partners","acquisition_amount":"N/A","structuredIssuesShow":"#Investment, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NcTPk2v32EKakyCTNgk2JOiZnhGSBsEJa4HmHFQdvD64l9NKjjQhNL","news_summary":"10 startups complete first cohort of SHAAR- Shaare Zedek - Arieli Healthcare innovation hub | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4QcebcT4ufTjHbYts9ZnmPbnH7Vp5fnzGDNmMLk3KdSt9eKSUlD9Rv","date":"Nov 16, 2022","link":"https://www.calcalistech.com/ctechnews/article/onm0t4d6s","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"digital medicine, technology incubator","company":"Sanara Ventures","layoffs":null,"summary":"Sanara Ventures has added two new Israeli startups, Panacea and ActiveAging, to its technology incubator. Panacea has developed a software system for optimizing clinical trials, while ActiveAging has developed an AI-based platform for managing personalized health benefits. Sanara Ventures focuses on startups in the pre-seed, Seed, and round A stages and has over 20 portfolio companies. They have also launched Sanara Capital, raising $100 million with Philips to invest in more advanced stage startups.","partners":null,"customers":null,"investors":"Philips","confidence":8,"key_topics":["Israeli startups","Panacea","ActiveAging","digital medicine","technology incubator"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$100 million","structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"WCphWTQpwgvx773qcFxrqYAOAMGpuswAt40jLeOBDsgQe61AorXBRQ","news_summary":"Sanara Ventures adds two medtech startups to tech incubator | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"00951e99-5c1b-45fd-a0df-ffe44d667977","date":"Oct 21, 2020","link":"https://www.prnewswire.com/news-releases/ben-gurion-university-researchers-develop-machine-learning-platform-to-streamline-clinical-trials-301156858.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"clinical trials, drug development","company":"Ben-Gurion University of the Negev (BGU)","layoffs":null,"summary":"Researchers at Ben-Gurion University of the Negev (BGU) have developed a novel platform to streamline clinical trials, lower costs, and increase the efficiency and success rate of the drug or medical device development process. The technology has been licensed for further development and commercialization to Panacea, a new company founded by BGN Technologies, the technology transfer company of BGU, and Prof. Boaz Lerner of the BGU Department of Industrial Engineering and Management, and Panaceas scientific founder. The new platform leverages machine learning to optimize a clinical trials chances of success. The technology has already been used in clinical studies of several neurodegenerative diseases and has demonstrated high performance.","partners":"Panacea","customers":null,"investors":null,"confidence":8,"key_topics":["clinical trials","machine learning","drug development","neurodegenerative diseases","technology transfer"],"date_of_event":"2020-10-21","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9YJlDoDQjH0Zsh8cbmTYTUDqIWpnhCPPqC10DTn2WJZ56fhsAug3XI","news_summary":"Ben-Gurion University Researchers Develop Machine Learning Platform to Streamline Clinical Trials","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":6,"techcommunityinvolvement":null,"mediagallery":[],"tags":["root-cause-analysis","degenerative-diseases","autoimmune-diseases","saas","predictive-analytics","digital-healthcare","artificial-intelligence","healthcare","biopharmaceutical","decision-support","pharma-companies","clinical-trials","machine-learning","rare-diseases","digital-twin","oncology","drug-development","data-analytics","neurology","metabolic-disease","clinical-data"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvVnp4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":[{"date":"2020-06-01","name":"Analysis, Prediction, Stratification, and Monitoring of ALS Disease Progression","tags":["degenerative-diseases","medical-technologies"],"category":"Medical Devices","tto_logo":"/image_cloud/bgn-technologies1_tto_logo_d432a8a3-6016-11e8-8ef8-41fdcbb0dda6","university_logo":"/image_cloud/bgn-technologies1_institution_logo_d432a8a3-6016-11e8-8ef8-41fdcbb0dda6"}],"usecases":[],"businessmodels":["B2B"],"productstage":"Beta","products":["PanaCT"],"geomarkets":["Global","Japan","Italy","Israel","France","Spain","Switzerland","United States","Denmark","Germany"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"Undisclosed","totalrounds":1,"fundingstage":"Pre-Seed","totalfunding":"Undisclosed","publicinvestors":2,"lastpublicfunding":0,"totalpublicrounds":1,"totalpublicfunding":0},"team":[{"name":"Raphael Giami","email":"raphael@panacea-ml.com","phone":"","gender":"Male","userid":"DZcDFwgtBFmOPyry2T3FkzUeSrYfP0fCJjgnZAvCj2fyrkdk7gz6IL","bounced":false,"claimed":1,"founder":0,"urlname":"raphael-giami","visible":1,"memberid":"I7PoYTcpHUZXYVabxDy9lKqv6v81OpAXrHHIwsKKF6I4FhVfi6Fsk2","position":"CEO","last_name":"Giami","claimtoken":"CwD7YnDBhqeFLNq3L7ZHB2RDmw5JapB93v5NuYIrpum9Xtnhseirjo","first_name":"Raphael","picturekey":"$PoQgmw8iD6Zd9qqB5Bc2dk4wDIXTvYO6ltOtaYxFnj2BpVzPRofL1m.jpeg","claimeddate":"2024-07-17","linkedinurl":"https://www.linkedin.com/in/raphael-giami-33789440/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-07-17 13:52:38.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$PoQgmw8iD6Zd9qqB5Bc2dk4wDIXTvYO6ltOtaYxFnj2BpVzPRofL1m.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Prof. Boaz Lerner","email":"boaz@panacea-ml.com","phone":"0544399763","gender":"Male","userid":"WbrmfDi5bJcWrTeeYtd6sj2vcFuUicquJ2wbLkpSItJLin1GkqKjxo","bounced":false,"claimed":0,"founder":1,"urlname":"boaz-lerner","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgxeXZnQkM","position":"Founder & CSO","last_name":"Lerner","claimtoken":"c99k7pFlrmw2ITONqMWpix570z71imCmovsFZ70jSCSJkyx3xugllZ","first_name":"Prof. Boaz","picturekey":"$k9vesEjAtnGrkJN0rp9lp9aSBc9lfffThe2KlPVwkW0XmVILazAaRE.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/boaz-lerner-ab696118a/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-29 15:20:51.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$k9vesEjAtnGrkJN0rp9lp9aSBc9lfffThe2KlPVwkW0XmVILazAaRE.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shay  Chaim","email":"shay@panacea-ml.com","phone":"","gender":"Male","userid":"17VHs7r4J6UYuUknGAJLC2Bwl8qvE9AqzGfsisQaiNTvSwh7JTaGiT","bounced":false,"claimed":null,"founder":0,"urlname":"shay-chaim","visible":1,"memberid":"rLHpTVqpHVs0idz8Gy3D66Tgp5bfx0OFoMDcf8cGxXfxLDxpWPSKiI","position":"VP R&D","last_name":"Chaim","claimtoken":"Izvgg8fuX2pBzbRSFzESWPh0fIXfBeouKfCAXDMazBu5SE666KfUsY","first_name":"Shay ","picturekey":"$vKPrmG3RZfL9OYrSund05mtI8mGswu7xyTdyNUfuC5vWh4RLFaii8D.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shay-chaim-74549613/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2023-11-28 14:04:34.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$vKPrmG3RZfL9OYrSund05mtI8mGswu7xyTdyNUfuC5vWh4RLFaii8D.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Roy Wolf","email":"roy@panacea-ml.com","phone":"","gender":"Male","userid":"YVdKV6tifX9m558lpl9VnLrANYOjLtP9yyWoKNQTo8TNlrzJKnQ65S","bounced":false,"claimed":null,"founder":0,"urlname":"roy-wolf","visible":1,"memberid":"OIOpWH9Euv7XTgQvs0fEiVSZzAgOjkiculN0fSsdniJTQ0VzeDwOI5","position":" Data Scientist & Algorithm Developer","last_name":"Wolf","claimtoken":null,"first_name":"Roy","picturekey":"$TLjlhMd7mgSEZvPYotcPo7LjPOiEc1GfTGQAhVK8iIygTEowvpAB9X.png","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/roywolf/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$TLjlhMd7mgSEZvPYotcPo7LjPOiEc1GfTGQAhVK8iIygTEowvpAB9X.png","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Anat Ohar","email":"anat@panacea-ml.com","phone":"","gender":"Female","userid":"BblapKR487DZaG6Wsuc5bZJLzdE7mTr6wO2nOg76NvLRbUtGtW5RuD","bounced":false,"claimed":null,"founder":0,"urlname":"anat-ohar","visible":1,"memberid":"aC0cCSOYN3uCUbQrKkpBTDtqsQsdwEqeyg04xSTnttDxJq1N5wF3by","position":"Marketing & OPS Lead","last_name":"Ohar","claimtoken":null,"first_name":"Anat","picturekey":"$9rv1ZhyqFSTfhUyB2SrP5AxQNrG1hTFcodcK56Cp7KhphHP8IMDH4s.png","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/anatohar/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$9rv1ZhyqFSTfhUyB2SrP5AxQNrG1hTFcodcK56Cp7KhphHP8IMDH4s.png","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPW8rMQKDA","fullname":"Lena Rogovina"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2020-10-08T00:00:00.000Z","crunchbaseid":"","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Shani Lachmanovich","creator_email":"shanilachmanovich@gmail.com","createdate":"2020-10-06T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":"Lena Rogovina","affiliatedOrganizations":null,"timeline":[{"id":"wrcA3TrQYOaojZidC1KDUlTUxjfFV7DUoHzGtR2gNXSSS5nanbsXvj","hub":"PharmStars","date":"May 2024","batch":"6","amount":"Undisclosed","hub_id":"KN71HuLtW3T3jHX87lJB4jov3ATcOkZsYxXL76a0ja5yfThiKLLbvJ","source":"","enddate":"Jul 2024","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":true,"investment":[],"hub_fullurl":"/program_page/pharmstars","hub_logokey":"$Sb7aeZP7HJgFX8CkSpm4wlu9LT8B3rT2mtw6Rjj8knZq3UcbbJhsPD.jpeg","hub_urlname":"/program_page/pharmstars","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$Sb7aeZP7HJgFX8CkSpm4wlu9LT8B3rT2mtw6Rjj8knZq3UcbbJhsPD.jpeg","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"XbrdxOzy2HEBQLduf9whJkkBeMVCDW6MFxfgy9yDYDeoxuP9w5gqqV","hub":"SHAAR Healthcare Innovation Hub","date":"Feb 2024","batch":"1","amount":"Undisclosed","hub_id":"UFmdMl1wA9ft246yLAgOQmDQie8c8SEWWYbYVKCiezgBrvF6apS0Pe","source":"","enddate":"Apr 2024","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/company_page/shaar-healthcare-innovation-hub","hub_logokey":"$oGHaD8in8BDpr38VErTQyQtNFF7JoHnq8DlFNazH5hYSE6lrKTSXrl.png","hub_urlname":"/company_page/shaar-healthcare-innovation-hub","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$oGHaD8in8BDpr38VErTQyQtNFF7JoHnq8DlFNazH5hYSE6lrKTSXrl.png","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"je8LacDXPsmFHcf23rI79l1Hz7gb0jMWuLlrlsdVhz0wWw0CArLLeS","date":"Nov 2022","amount":"Undisclosed","source":"https://www.calcalistech.com/ctechnews/article/onm0t4d6s","eventtype":"FundingRoundEvent","investment":[{"name":"Sanara Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/sanara-ventures","logokey":"$pCINnhSb1FCS8QFpUZa9iXAcmF6mwSg4xOwclvsGSh7L05WzoO7Ury","tagline":null,"urlname":"/investor_page/sanara-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNXVspkKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"Zn1x8GJaCOEs5PsHYffX9ciWGdUbMmijLmv6uArcgYEyLElwv51r4c","fundingsubtype":"Incubator","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pCINnhSb1FCS8QFpUZa9iXAcmF6mwSg4xOwclvsGSh7L05WzoO7Ury","leadcaption":"Lead ","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":null,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"PUY54mKGl26ajcYAb7ww6nY7ARqV8Pd6cimVQd8kUlL0lrKvPIMdnj","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCl6tDECgw","hub":"Oazis","date":"May 2020","batch":"1","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JaWhfQJDA","source":"https://www.jpost.com/health-science/ben-gurion-university-launches-oazis-its-academic-accelerator-642197","enddate":"Sep 2020","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/program_page/oazis","hub_logokey":"$vehrSO5ygtI3cAYI5cyjd6z0wAZNqFqV8qAfGs3WTBwPQIPbrfiton","hub_urlname":"/program_page/oazis","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$vehrSO5ygtI3cAYI5cyjd6z0wAZNqFqV8qAfGs3WTBwPQIPbrfiton","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"8/2022","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Panacea-ml","logourl":"https://storage.googleapis.com/clean-finder-353810/$SQLubmi6UarQh2L1UldHkmht32oNI2tdI4hMHGtndORZNhVWBasrUY.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$SQLubmi6UarQh2L1UldHkmht32oNI2tdI4hMHGtndORZNhVWBasrUY.png","seoabout":"Spun out of Ben Gurion University, Panacea-ml is disrupting clinical development with its “Explainable AI” platform. \n\nWe tackle the main causes of trial f...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":5,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"API","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvVnp4JDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Insurance Companies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>API#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvVnp4JDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Insurance Companies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/API#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvVnp4JDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Insurance Companies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Biotechnology","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"},{"title":"Pharmaceuticals","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]},{"title":"Healthcare","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Insurance Companies","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Insurance Companies"},{"title":"Providers","key":"0-0-1-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Platforms & Interfaces","key":"0-0","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"API","key":"0-0-0","path":"TechnologyClassificationModel>Platforms & Interfaces>API"},{"title":"Software","key":"0-0-1","path":"TechnologyClassificationModel>Platforms & Interfaces>Software"}]},{"title":"Artificial Intelligence","key":"0-1","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Machine Learning","key":"0-1-0","path":"TechnologyClassificationModel>Artificial Intelligence>Machine Learning"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"API","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvVnp4JDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Insurance Companies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Platforms & Interfaces","API","Software","Artificial Intelligence","Machine Learning"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Biotechnology","Pharmaceuticals","Healthcare","Insurance Companies","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"je8LacDXPsmFHcf23rI79l1Hz7gb0jMWuLlrlsdVhz0wWw0CArLLeS","date":"Nov 2022","amount":"Undisclosed","source":"https://www.calcalistech.com/ctechnews/article/onm0t4d6s","eventtype":"FundingRoundEvent","investment":[{"name":"Sanara Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/sanara-ventures","logokey":"$pCINnhSb1FCS8QFpUZa9iXAcmF6mwSg4xOwclvsGSh7L05WzoO7Ury","tagline":null,"urlname":"/investor_page/sanara-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNXVspkKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"Zn1x8GJaCOEs5PsHYffX9ciWGdUbMmijLmv6uArcgYEyLElwv51r4c","fundingsubtype":"Incubator","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pCINnhSb1FCS8QFpUZa9iXAcmF6mwSg4xOwclvsGSh7L05WzoO7Ury","leadcaption":"Lead ","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":null,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"PUY54mKGl26ajcYAb7ww6nY7ARqV8Pd6cimVQd8kUlL0lrKvPIMdnj","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}